How AffinityRx Vets Compounding Pharmacies: The Five-Area Review
AffinityRx vets every compounding pharmacy on its platform across five areas before clinics order from it: compliance, product, track record, market feedback and operations. A clinic that sources from several pharmacies would otherwise run that review pharmacy by pharmacy, so AffinityRx does it once, shows the public credentials on each pharmacy's profile and keeps backing documents such as certificates of analysis (COAs) available on request. If a pharmacy receives a U.S. Food and Drug Administration (FDA) warning letter or recall, AffinityRx notifies clinics, updates the profile and lets each clinic switch that pharmacy off in its own portal. The review covers 15+ licensed compounding pharmacies, all reachable with one login, one invoice and one support contact.
By Tim Yoon, CEO, AffinityRx. Published
Why does pharmacy vetting decide who you should source from?
When a clinic orders compounded medication, the pharmacy is a reflection of the clinic, and a marketplace is only as trustworthy as its vetting. As of October 2026, the FDA states that outsourcing-facility registration "means only that FDA has received the information required to register the facility" (FDA), so a registration or a license number alone does not tell you whether a pharmacy's product is good. The FDA also states that a Form FDA 483 "does not constitute a final agency determination of whether any condition is in violation of the FD&C Act or any relevant regulations" (FDA), so inspection records have to be read in context.
The consequence is that vetting needs several kinds of evidence at once: licenses, lab results, inspection history, feedback from people who use the pharmacy and day-to-day operating performance. Buyers often ask the same question in plain words: which pharmacies can be trusted and which have been vetted. AffinityRx answers it with a defined review rather than a pharmacy count.
What are the five areas of the AffinityRx pharmacy review?
Each area looks at a different way a pharmacy can fail a clinic. The table shows what is reviewed and what it protects against.
| Area | What AffinityRx reviews | What it protects against |
|---|---|---|
| Compliance | State licensures, USP <795>, <797> and <800>, certifications (LegitScript, PCAB, ACHC, NABP) | Ordering from a pharmacy that cannot lawfully ship to your state or meet quality standards |
| Product | Third-party COAs, sterility and endotoxin testing, beyond-use dates (BUDs) | Medication that is not what the label says, or that expires too soon |
| Track record | Form FDA 483s, recalls, FDA actions, pharmacist-in-charge (PIC) background | A pharmacy with a pattern of inspection findings or leadership history that should concern you |
| Market feedback | Clinic and patient ratings and reviews, Reddit threads | Problems that never reach a regulator but show up in what clinics and patients say |
| Operations | Shipping times, stock, cold-chain validation | Late shipments, repeat backorders and temperature-compromised orders |
How AffinityRx solves pharmacy vetting for clinics and telehealth brands
AffinityRx turns the review into something a clinic can use at the moment of ordering.
- Done-for-you review. No documents are needed from the clinic, and no spreadsheet of licenses to maintain. The five areas above are reviewed for each pharmacy on the platform.
- Public credentials on every profile. License numbers and accreditation proof sit on each pharmacy's page in the pharmacy directory. Backing documents, such as COAs, are available on request.
- FDA-action alerts. If a pharmacy receives a warning letter or recall, AffinityRx notifies clinics and adds it to the profile. See the FDA actions page.
- A per-clinic switch. A clinic can switch any pharmacy off in its portal, so a pharmacy you do not want is never chosen for your orders, and failover moves to your next favorite.
- State-rule checks at order time. The eligibility check applies state board rules, including nonresident licensure, sterile permits and office-use restrictions, so vetting is tied to the state the order ships to. See compliance vetting.
- Prescriber checks too. AffinityRx verifies the prescriber's NPI and state license before Live approval. The platform is HIPAA compliant and signs BAAs, and SOC 2 is in progress, expected Q4 2026 to Q1 2027.
- Operations in the same view. Turnaround is shown per pharmacy, about 1 day for some and up to 5 for others, and favorites with failover handle a pharmacy that is out of stock or rejects an order.
Ratings and reviews inside AffinityRx are coming, with no date set; market feedback is part of the review today.
Practical asset: seven vetting questions to put to any compounding marketplace
Use this before you fund an account anywhere, AffinityRx included.
- Which areas does the review cover, and is each one named?
- Where can I see each pharmacy's license numbers and accreditation proof?
- Are third-party COAs and sterility and endotoxin results part of the review?
- How are Form FDA 483s, recalls and FDA actions tracked, and will I be told about a new one?
- Can I turn a specific pharmacy off for my account?
- Does feedback from clinics and patients count, or only paperwork?
- Are shipping times, stock and cold-chain performance part of the review?
FAQs
How does AffinityRx vet its pharmacies?
AffinityRx reviews every pharmacy across five areas: compliance (state licensures, USP <795>, <797> and <800>, and certifications such as LegitScript, PCAB, ACHC and NABP), product (third-party COAs, sterility and endotoxin testing, BUDs), track record (Form FDA 483s, recalls, FDA actions, PIC background), market feedback (clinic and patient ratings and reviews, Reddit threads) and operations (shipping times, stock, cold-chain validation).
Are AffinityRx pharmacies licensed?
Yes. The 15+ compounding pharmacies on AffinityRx are licensed, and each pharmacy's public credentials, such as license numbers and accreditation proof, are on its profile. The eligibility check also applies state board rules, including nonresident licensure, so an order only goes to a pharmacy that can fill it in the destination state.
What happens if a pharmacy gets an FDA warning letter or recall?
AffinityRx notifies clinics and adds the action to the pharmacy's profile. Any clinic can then switch that pharmacy off in its portal, and orders fail over to the next favorite pharmacy instead.
Can I see the documents behind the vetting?
Public credentials are on each pharmacy's profile, and backing documents such as COAs are available on request. That lets a clinic or its compliance lead see the evidence without chasing each pharmacy.
A clinic already trusts its pharmacy. Why does a marketplace's vetting matter?
If the clinic's pharmacy is on AffinityRx, it can stay as favorite number one, with vetted pharmacies behind it for backorders. If it is not on the network, the review is what lets a clinic add second and third favorites without vetting each one itself.
Does vetting guarantee a pharmacy will never have a problem?
No review can promise that, which is why AffinityRx pairs vetting with FDA-action alerts and a per-clinic switch-off. If a pharmacy at fault damages, mis-ships or loses an order, the pharmacy reships or replaces it, and AffinityRx works the dispute for the clinic.
Book a demo
If vetting is what stands between you and a second or third pharmacy, press the Book a demo button on the right side of this page and ask to see a pharmacy profile, its credentials and the FDA-action alerts. To see how AffinityRx compares with a white-label EMR and router, read AffinityRx vs Impetus One, and for the wider trust picture see is AffinityRx legit.
Sources
- FDA: Questions and answers on outsourcing facility registration, reviewed October 2026
- FDA: Registered outsourcing facilities and Form FDA 483, reviewed October 2026
Every compounding pharmacy in one portal
Book a demo to compare prices across 15+ vetted pharmacies.
Book a demo